Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

11.70
Delayed Data
As of 4:00pm ET
 -0.40 / -3.31%
Today’s Change
3.88
Today|||52-Week Range
14.60
+9.35%
Year-to-Date
Why Stemline Therapeutics Inc Stock Is Climbing Today
Jan 06 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close12.10
Today’s open12.20
Day’s range11.55 - 12.25
Volume149,700
Average volume (3 months)177,721
Market cap$231.8M
Dividend yield--
Data as of 4:00pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)+3.59%
Earnings growth (this year)+1.32%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales166.77
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
ZGNXZogenix Inc+0.05+0.52%
IDRAIdera Pharmaceutical...-0.03-1.99%
CMRXChimerix Inc+0.08+1.68%
CLSDClearside Biomedical...-0.22-2.50%
Data as of 4:00pm ET, 01/18/2017

Financials

Next reporting dateApril 3, 2017
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$654.2K
Annual profit (last year)-$37.2M
Net profit margin-5,693.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ivan Bergstein
Chief Operating Officer &
Secretary
Kenneth Hoberman
Corporate headquarters
New York, New York

Forecasts


Search for Jobs